Bausch Health Companies Inc (TSE:BHC) – Stock analysts at Piper Jaffray Companies raised their Q2 2019 earnings per share estimates for shares of Bausch Health Companies in a research note issued to investors on Monday, May 6th, Zacks Investment Research reports. Piper Jaffray Companies analyst D. Amsellem now forecasts that the company will post earnings of $1.39 per share for the quarter, up from their prior forecast of $1.32. Piper Jaffray Companies also issued estimates for Bausch Health Companies’ Q3 2019 earnings at $1.37 EPS, Q4 2019 earnings at $1.48 EPS, FY2019 earnings at $5.58 EPS, Q1 2020 earnings at $1.18 EPS, Q2 2020 earnings at $1.55 EPS, Q3 2020 earnings at $1.57 EPS, Q4 2020 earnings at $1.70 EPS, FY2020 earnings at $6.00 EPS, FY2022 earnings at $7.33 EPS and FY2023 earnings at $7.94 EPS.
Bausch Health Companies (TSE:BHC) last released its earnings results on Monday, May 6th. The company reported C$1.37 EPS for the quarter, topping the consensus estimate of C$1.18 by C$0.19. The business had revenue of C$2.68 billion for the quarter, compared to analyst estimates of C$2.70 billion.
TSE:BHC traded down C$0.91 on Tuesday, hitting C$28.06. The stock had a trading volume of 1,036,510 shares, compared to its average volume of 859,763. The firm has a market cap of $10.19 billion and a P/E ratio of -6.09. The company has a debt-to-equity ratio of 878.70, a quick ratio of 0.65 and a current ratio of 1.09. Bausch Health Companies has a 52 week low of C$23.60 and a 52 week high of C$36.52.
About Bausch Health Companies
Bausch Health Companies Inc develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products.
Featured Story: Understanding debt-to-equity ratio in fundamental analysis
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.